i-Base home
Search Menu
  • Home
  • HTB
  • 2018
  • March
  • 30

HTB

30 March 2018

Contents

Editorial

  • 30 March 2018: vol 19 no 6 – CROI 2018 part 2

Conference reports

  • CROI 2018: second reports
  • Ibalizumab 24-week phase 3 results and susceptibility to drug-resistant HIV
  • Statin use might reduce risk of cancer in HIV positive people
  • Rate of bone loss on ART slows after the first year
  • Standard dose of dolutegravir sufficient in late pregnancy: interim results from DolPHIN-1 study
  • Women’s risk of becoming HIV positive increases three-fold in late pregnancy and four-fold postpartum
  • Cure research at CROI 2018: defining and reducing the reservoir and the risks from interrupting treatment

HIV prevention and transmission

  • Update on PrEP IMPACT study (March 2018)

Cure research

  • Elite controllers: sex differences and factors associated with loss of immune control
  • Assessing antiretroviral therapy interruptions in HIV cure research

Other news

  • US Congress rejects Trump’s proposed cuts to research budget for 2018

On the web

  • HCV advocacy training manual

PDFs

  • 30 March 2018: vol 19 no 6
  • HTB RSS

Early access

  • Monkeypox cases in gay men in the UK: BHIVA statement 19 May 2022
  • Implications of SARS-CoV-2 in gut tissue for transmission of COVID-19 and long COVID 19 May 2022
  • Lenacapavir in MDR HIV: phase 3 results of CAPELLA study published 12 May 2022
  • All early access reports

Current issues

  • May 2022
  • April 2022
  • March 2022
  • Back issues

Special report

  • EACS statement on the war in Ukraine 1 March 2022

More from HTB

  • Conference reports
  • Conference shortcuts
  • Articles by subject
  • PDFs
  • Subscribe
  • HTB homepage

Home

  • i-Base homepage

This website sets no cookies from us or anyone else.

Information on this website is provided by treatment advocates and offered as a guide only. Decisions about your treatment should always be taken in consultation with your doctor.

This site complies with the HONcode standard for trustworthy health information.

Verify here.

HIV i-BASE
About us - Contact - Cookies and privacy - Copyright waiver - Terms of use - Home
107 The Maltings, 169 Tower Bridge Road, London SE1 3LJ.
Tel + 44 (0) 208 616 2210. Email admin@i-base.org.uk
Registered charity no: 1081905. Company reg no: 3962064.

Search i-Base

Site navigation

Quick links
HIV positive
Advocate
Professional
Donate
Feedback
Advice and information
Q and A
Phoneline
Pocket info
Guides
HIV meds
Glossary
Research and conference reports
HTB
HTB South
Pipeline report
Publications and resources
Publications
Other resources
Translations
Slide sets
Order and subscribe
News and updates
News
Blogs
Advocates' network
UK-CAB
Training manual
i-Base
About us
Contact
Sitemap
Home
Find us on Facebook
i-Base on Facebook